<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38614374</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-1186</ISSN><JournalIssue CitedMedium="Internet"><Volume>204</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pharmacological research</Title><ISOAbbreviation>Pharmacol Res</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19.</ArticleTitle><Pagination><StartPage>107170</StartPage><MedlinePgn>107170</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phrs.2024.107170</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1043-6618(24)00114-2</ELocationID><Abstract><AbstractText>To determine the effects of SARS-CoV-2 infection on cellular metabolism, we conducted an exhaustive survey of the cellular metabolic pathways modulated by SARS-CoV-2 infection and confirmed their importance for SARS-CoV-2 propagation by cataloging the effects of specific pathway inhibitors. This revealed that SARS-CoV-2 strongly inhibits mitochondrial oxidative phosphorylation (OXPHOS) resulting in increased mitochondrial reactive oxygen species (mROS) production. The elevated mROS stabilizes HIF-1&#x3b1; which redirects carbon molecules from mitochondrial oxidation through glycolysis and the pentose phosphate pathway (PPP) to provide substrates for viral biogenesis. mROS also induces the release of mitochondrial DNA (mtDNA) which activates innate immunity. The restructuring of cellular energy metabolism is mediated in part by SARS-CoV-2 Orf8 and Orf10 whose expression restructures nuclear DNA (nDNA) and mtDNA OXPHOS gene expression. These viral proteins likely alter the epigenome, either by directly altering histone modifications or by modulating mitochondrial metabolite substrates of epigenome modification enzymes, potentially silencing OXPHOS gene expression and contributing to long-COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guarnieri</LastName><ForeName>Joseph W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haltom</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albrecht</LastName><ForeName>Yentli E Soto</ForeName><Initials>YES</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lie</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA; Department of Biology, University of Pennsylvania,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olali</LastName><ForeName>Arnold Z</ForeName><Initials>AZ</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widjaja</LastName><ForeName>Gabrielle A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranshing</LastName><ForeName>Sujata S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelin</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murdock</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Douglas C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA; Department of Pediatrics, Division of Human Genetics, Perelman School of Medicine, University of Pennsylvania,&#xa0;Philadelphia,&#xa0;PA 19104,&#xa0;USA. Electronic address: WallaceD1@chop.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Pharmacol Res</MedlineTA><NlmUniqueID>8907422</NlmUniqueID><ISSNLinking>1043-6618</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="Y">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010085" MajorTopicYN="Y">Oxidative Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057890" MajorTopicYN="N">Epigenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epigenome</Keyword><Keyword MajorTopicYN="N">Gene regulation</Keyword><Keyword MajorTopicYN="N">Inhibitors</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">OXPHOS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest D.C.W. serves on the advisory boards of Plano Therapeutics and Medical Excellence Capital.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38614374</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2024.107170</ArticleId><ArticleId IdType="pii">S1043-6618(24)00114-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>